KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GSK) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$225.3 million.

  • Gsk's Interest Expenses fell 1115.01% to -$225.3 million in Q3 2025 from the same period last year, while for Dec 2025 it was -$674.8 million, marking a year-over-year increase of 5475.9%. This contributed to the annual value of $855.2 million for FY2024, which is 1319.06% down from last year.
  • According to the latest figures from Q3 2025, Gsk's Interest Expenses is -$225.3 million, which was down 1115.01% from -$245.5 million recorded in Q2 2025.
  • Gsk's 5-year Interest Expenses high stood at -$202.7 million for Q3 2024, and its period low was -$1.0 billion during Q4 2022.
  • In the last 5 years, Gsk's Interest Expenses had a median value of -$246.7 million in 2023 and averaged -$353.5 million.
  • Per our database at Business Quant, Gsk's Interest Expenses surged by 1969.71% in 2021 and then plummeted by 30682.64% in 2022.
  • Quarter analysis of 5 years shows Gsk's Interest Expenses stood at -$253.4 million in 2021, then tumbled by 306.83% to -$1.0 billion in 2022, then increased by 4.66% to -$983.0 million in 2023, then rose by 12.65% to -$858.7 million in 2024, then surged by 73.76% to -$225.3 million in 2025.
  • Its Interest Expenses was -$225.3 million in Q3 2025, compared to -$245.5 million in Q2 2025 and -$204.0 million in Q1 2025.